HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

B Dean Selected Research

Pirenzepine

11/2009Decreased cortical muscarinic receptors define a subgroup of subjects with schizophrenia.
12/2006[3H]Pirenzepine binding in the pathology of schizophrenia: studies in Brodmann's area 6.
1/2002Decreased muscarinic1 receptors in the dorsolateral prefrontal cortex of subjects with schizophrenia.
6/2001Low muscarinic receptor binding in prefrontal cortex from subjects with schizophrenia: a study of Brodmann's areas 8, 9, 10, and 46 and the effects of neuroleptic drug treatment.
9/2000Decreased muscarinic receptor binding in subjects with schizophrenia: a study of the human hippocampal formation.
3/2000Muscarinic1 and 2 receptor mRNA in the human caudate-putamen: no change in m1 mRNA in schizophrenia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


B Dean Research Topics

Disease

43Schizophrenia (Dementia Praecox)
01/2018 - 01/2000
12Bipolar Disorder (Manic Depressive Psychosis)
01/2017 - 10/2001
9Mental Disorders (Mental Disorder)
01/2018 - 03/2001
5Major Depressive Disorder (Major Depressive Disorders)
01/2017 - 08/2009
3Mood Disorders (Mood Disorder)
08/2015 - 07/2013
2Inflammation (Inflammations)
11/2016 - 01/2011
1Wounds and Injuries (Trauma)
01/2018
1Foreign Bodies (Foreign Body)
01/2018
1Venous Thromboembolism
05/2010
1Psychotic Disorders (Schizoaffective Disorder)
04/2010
1Alzheimer Disease (Alzheimer's Disease)
01/2002

Drug/Important Bio-Agent (IBA)

12Muscarinic Receptors (Muscarinic Acetylcholine Receptor)IBA
01/2018 - 09/2000
11Cholinergic Agents (Cholinergics)IBA
01/2015 - 08/2000
9Messenger RNA (mRNA)IBA
01/2018 - 03/2000
8Proteins (Proteins, Gene)FDA Link
01/2017 - 01/2000
6Dopamine (Intropin)FDA LinkGeneric
01/2012 - 01/2001
6PirenzepineIBA
11/2009 - 03/2000
3Muscarinic M1 ReceptorIBA
01/2018 - 06/2012
3Protein Isoforms (Isoforms)IBA
01/2017 - 01/2002
3EnzymesIBA
11/2016 - 02/2003
3Biomarkers (Surrogate Marker)IBA
01/2016 - 11/2009
3gamma-Aminobutyric Acid (GABA)IBA
01/2016 - 01/2001
3Pharmaceutical PreparationsIBA
08/2015 - 11/2009
3Acetylcholine (Acetylcholine Chloride)FDA Link
04/2010 - 01/2001
3Neurotransmitter Agents (Neurotransmitter)IBA
03/2007 - 03/2002
3N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA
08/2003 - 07/2000
3GABA-A Receptors (GABA(A) Receptor)IBA
10/2001 - 01/2001
2Phospholipase C betaIBA
01/2017 - 07/2008
2MicroRNAs (MicroRNA)IBA
01/2016 - 02/2013
2Nitric Oxide Synthase (NO Synthase)IBA
01/2016 - 10/2001
2Glutamic Acid (Glutamate)FDA Link
01/2016 - 07/2008
2Antipsychotic Agents (Antipsychotics)IBA
06/2012 - 06/2001
25-HT2A Serotonin Receptor (5 HT2A Receptor)IBA
01/2012 - 07/2000
2LigandsIBA
01/2012 - 07/2000
2Cholinergic ReceptorsIBA
04/2010 - 09/2000
2Biological ProductsIBA
11/2009 - 07/2000
2AFDX 384IBA
08/2009 - 03/2000
2ApolipoproteinsIBA
12/2006 - 01/2002
2AMPA Receptors (AMPA Receptor)IBA
08/2003 - 07/2000
2N-Methylaspartate (NMDA)IBA
08/2003 - 07/2000
2alpha- Amino- 3- hydroxy- 5- methyl- 4- isoxazolepropionic Acid (AMPA)IBA
08/2003 - 07/2000
2Kainic Acid (Kainate)IBA
08/2003 - 07/2000
2Ionotropic Glutamate ReceptorsIBA
08/2003 - 07/2000
2Apolipoproteins D (Apo D)IBA
02/2003 - 03/2001
2Serotonin (5 Hydroxytryptamine)IBA
01/2001 - 01/2001
1Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA
01/2017
1Fatty Acids (Saturated Fatty Acids)IBA
01/2017
1Lactic Acid (Lactate)FDA LinkGeneric
11/2016
1Glucose (Dextrose)FDA LinkGeneric
11/2016
1Acetyl Coenzyme A (Acetyl-CoA)IBA
11/2016
1Pyruvic Acid (Pyruvate)IBA
11/2016
1Oxidoreductases (Dehydrogenase)IBA
11/2016
1Interleukin-6 (Interleukin 6)IBA
11/2016
1Arginine (L-Arginine)FDA Link
01/2016
1AgmatineIBA
01/2016
1Amino AcidsFDA Link
01/2016
1Aminobutyrates (Aminobutyric Acid)IBA
01/2016
1ArginaseIBA
01/2016
1CitrullineIBA
01/2016
1OrnithineIBA
01/2016
1Selenium-Binding ProteinsIBA
08/2015
1Beclin-1IBA
02/2015
1Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA
07/2013
1Type I Tumor Necrosis Factor ReceptorsIBA
07/2013
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
07/2013
1InterleukinsIBA
07/2013
1Type II Tumor Necrosis Factor ReceptorsIBA
07/2013
1butyl phosphorotrithioate (DEF)IBA
02/2013
1Muscarinic M4 ReceptorIBA
06/2012
1Neurotransmitter Receptors (Neurotransmitter Receptor)IBA
01/2012
1Dopamine D2 Receptors (Dopamine D2 Receptor)IBA
01/2012
1Histone Deacetylase InhibitorsIBA
12/2011
1Histone Deacetylases (Histone Deacetylase)IBA
12/2011
1Histones (Histone)IBA
12/2011
1ChromatinIBA
12/2011
1Nerve Growth Factors (Neurotrophins)IBA
01/2011
1Cholinesterase Inhibitors (Anticholinesterases)IBA
04/2010
1Neural Cell Adhesion Molecules (Neural Cell Adhesion Molecule)IBA
07/2009
1Serotonin ReceptorsIBA
07/2008
1Clozapine (Clozaril)FDA LinkGeneric
07/2008
1mu Opioid Receptors (mu Opioid Receptor)IBA
12/2006
1SynaptophysinIBA
04/2006
1Qa-SNARE Proteins (Syntaxin)IBA
04/2006
1Cell Adhesion MoleculesIBA
04/2006
1R-SNARE Proteins (Vesicle-Associated Membrane Protein)IBA
04/2006
1Dynamin IIBA
04/2006
1alpha-SynucleinIBA
04/2006
1iodosulprideIBA
05/2004
1SpiperoneIBA
05/2004
1Haloperidol (Haldol)FDA LinkGeneric
05/2004
1Dizocilpine Maleate (Dizocilpine)IBA
08/2003
1Ion Channels (Ion Channel)IBA
08/2003
1ImmunosorbentsIBA
02/2003
1Phorbol EstersIBA
01/2002
1Protein Kinase CIBA
01/2002
1Phorbol 12,13-DibutyrateIBA
01/2002

Therapy/Procedure

2Therapeutics
01/2016 - 05/2001
1Critical Care (Surgical Intensive Care)
01/2018
1Thoracotomy
01/2018
1Arthroplasty
05/2010